Sublingual Methadone for the Management of Cancer Breakthrough Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00125294
Recruitment Status : Completed
First Posted : August 1, 2005
Last Update Posted : September 25, 2017
Calgary Health Region
Information provided by (Responsible Party):
AHS Cancer Control Alberta

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2006
  Actual Study Completion Date : January 2007